Continuous Low-pH Virus Inactivation: Challenges and Practical Solutions

Johnson SA , Brown MR , Lute SC , Brorson KA . 2017. Adapting viral safety assurance strategies to continuous processing of biological products. Biotechnol. Bioeng. , 114(1): 21–32

Zydney AL . 2016. Continuous downstream processing for high value biological products: A review. Biotechnol. Bioeng. , 113(3): 465–475.

Klutz SL , Lobedann M , Bramsiepe C , Schembecker G . 2016. Continuous viral inactivation at low pH value in antibody manufacturing. Chem. Eng. Process. , 102: 88–101.

Lobedann M , Klutz S , Klutz S , Kurt SK . 2016. Device and method for continuous virus inactivation. U.S. patent application US20160375159A1.

Coffman J , Goby J , Godfrey S , Orozco S , Vogel JH . 2017. Methods, apparatuses, and systems for continuously inactivating a virus during manufacture of a biological product. U.S. patent application US20170037381A1.

Bolton GR , Selvitelli KR , Iliescu I , Cecchini DJ . 2015. Inactivation of viruses using novel protein A wash buffers. Biotechnol. Prog. , 31: 406–413.

Soice N , Hubbard JD , Zhang Y , Hamzik J . 2011. Methods for purifying a target protein from one or more impurities in a sample. U.S. patent application US20110065901A1. C07K 1/22 (20060101); C07K16/00 (20060101); B01D 15/08 (20060101).

Arnold L , Lee K , Rucker-Pezzini J , Lee JH . 2018. Implementation of fully integrated continuous antibody processing: Effects on productivity and COGm. Biotechnol. J. doi: 10.1002/biot.201800061. [Epub ahead of print]